Dr. Mcfaline-Figueroa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
450 Brookline Ave.
Boston, MA 02215Phone+1 617-632-2166Fax+1 617-632-4773
Summary
- Dr. J. Ricardo Mcfaline-Figueroa is a neurologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 3 years. He also speaks multiple languages, including Spanish. He specializes in neurooncology and is experienced in neuro-oncology and neurology.
Education & Training
- Massachusetts General HospitalFellowship, Neuro-Oncology, 2017 - 2018
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2014 - 2017
- Massachusetts General HospitalInternship, Internal Medicine, 2013 - 2014
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2013
Certifications & Licensure
- NH State Medical License 2024 - 2026
- MA State Medical License 2013 - 2025
- NY State Medical License 2024 - 2025
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- Paul Calabresi Career Development Award for Clinical Oncology (K12) National Cancer Institute; Dana-Farber/Harvard Cancer Center
Publications & Presentations
PubMed
- 2 citationsEvaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.Davy Deng, Lubna Hammoudeh, Gilbert Youssef, Yu-Hui Chen, Kee-Young Shin
Neuro-Oncology Advances. 2023-07-08 - 10 citationsTelomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.Elisa Aquilanti, Lauren Kageler, Jacqueline Watson, Duncan M Baird, Rhiannon E Jones
Neuro-Oncology. 2023-07-06 - 17 citationsEvaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology i...Gilbert Youssef, Rifaquat Rahman, Camden Bay, Wei Wang, Mary Jane Lim-Fat
Journal of Clinical Oncology. 2023-06-10
Grant Support
- Amos Medical Faculty Development ProgramRobert Wood Johnson Foundation2021–2024
- Sharpe-NBTS 2019-2020 GBM Research AwardNational Brain Tumor Society2019–2021
- SPORE in Brain Cancer Career Enhancement ProgramDana-Farber/Harvard Cancer Center2019–2020
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: